About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Advertisement

Medindia » Health Press Releases A-Z

Aoxing Pharmaceutical Company Announces Conference Call to Discuss Joint Venture with Johnson Matthey PLC Following the Chinese Government Signing Ceremony

Advertisement

- Call to discuss landmark deal to develop narcotics and neurological pharmaceutical products in China scheduled for May 13, 2010 -

Aoxing Pharmaceutical Company, Inc.

Investor Relations Contact:
Brian Korb
Vice President
The Troup Group LLC
Tel: +1 646 378 2923
Email: [email protected]

Sponsored Post and Backlink Submission

Latest Press Release on General News

Born Free USA Expresses Concern for 43 Rhesus Macaques Escaped from South Carolina Laboratory, Urges Laboratory to Rehome the Monkeys to Sanctuary

PR Newswire COTULLA, Texas, Nov. 7, 2024 COTULLA, Texas, Nov. 7, 2024 /PRNewswire/ -- Following the disturbing news that 43 monkeys have escaped the Alpha Genesis research facility i...

ELNA Medical Group and TELUS Health Announce Groundbreaking Partnership to Advance Canadian Healthcare

Canada NewsWire MONTREAL, Nov. 7, 2024 MONTREAL, Nov. 7, 2024 /CNW/ - ELNA Medical Group, Canada's largest network of medical clinics & diagnostic laboratories, is thrilled to announ...

American Joint Replacement Registry Surpasses 4 Million Captured Hip and Knee Arthroplasty Procedures

PR Newswire ROSEMONT, Ill., Nov. 7, 2024 Newly released 11th Annual Report offers insight into arthroplasty trends in the United States; surgeon dashboards guide physicians in optimi...

Surgeons Address the Urgent Need to Eliminate 'Blood Deserts'

PR Newswire CHICAGO, Nov. 7, 2024 An estimated 10,000 lives could be saved each year with quicker access to blood in the field for injured patients, experts said during an American C...

Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders

PR Newswire OAKLAND, Calif. and NANJING, China, Nov. 7, 2024 Leads Biolabs grants Oblenio Bio an exclusive option to license LBL-051, a first-in-class CD19xBCMAxCD3 tri-specific T-ce...

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use Ok, Got it. Close